BioLife Solutions BLFS Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.19M+365% | —— | $621K+136% | -$15.84M+23.6% | -$448K+95.6% | ||
| $374K-45.2% | $261K-72.1% | $636K-54.8% | $674K-53.6% | $682K-50.0% | ||
| $4.81M+15.7% | $7.08M-33.8% | $5.9M+10.8% | $5.86M-32.8% | $4.15M-32.8% | ||
| $9K+50.0% | $0— | $14K+115% | $45K— | $6K+20.0% | ||
| $5.1M+510,500% | -$1.94M-257% | $782K— | $893K-53.9% | -$1K+98.5% | ||
| $2.68M+285% | $2.33M— | —— | —— | -$1.45M-3,345% | ||
| $2.21M+366% | -$952K-182% | -$679K-82.0% | —— | -$828K+57.7% | ||
| -$4.4M-3.5% | —— | —— | —— | -$4.25M-50.5% | ||
| $26K+62.5% | $264K— | $0+100% | -$16K— | $16K+104% | ||
| -$148K+54.7% | -$1.39M-1,549% | $0+100% | -$298K+27.0% | -$327K-1,735% | ||
| -$491K-128% | $4.92M+199% | $6.1M+27.1% | $7.37M+14.1% | $1.73M+139% | ||
| $167K-4.6% | $9.03M+188% | $360K— | $0-100% | $175K+573% | ||
| $20.43M-32.6% | $36.67M+1,427% | $13.09M+147% | $33.98M+683% | $30.32M+376% | ||
| $2.33M+307% | $3.24M+256% | $1.84M+124% | $1.18M+44.7% | $573K-41.1% | ||
| —— | $5.88M-68.0% | $5.88M-68.0% | $5.88M-68.0% | $5.88M-68.0% | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| -$1.83M+93.3% | $0-100% | -$5.97M-255% | -$39.53M-194% | -$27.18M-12,197% | ||
| $190K— | -$18K+86.9% | $0-100% | $18K-80.2% | $0— | ||
| $5.59M— | —— | —— | —— | $0— | ||
| $3K-70.0% | $4K+107% | $9K— | $10K+121% | $10K-37.5% | ||
| -$7.9M-164% | -$2.5M+38.9% | -$2.56M-146% | -$2.88M-309% | -$2.99M-214% | ||
| -$10.22M+64.1% | $0-100% | -$2.42M-216% | -$35.04M-356% | -$28.44M-404% | ||
| $73K-72.5% | $118K-68.3% | $164K-59.7% | $215K-44.0% | $265K-40.4% | ||
| $122K+16.2% | $201K+200% | $230K+158% | $200K+47.1% | $105K-42.3% | ||
| $325K-53.7% | $325K-57.6% | $699K-23.2% | $708K-22.2% | $702K-23.2% | ||
| $0+100% | $0+100% | -$167K-35.8% | -$156K-13.9% | -$187K+5.6% | ||
| —— | $0— | $0— | $0— | $0— | ||
| —— | $2.58M-35.0% | $2.58M-35.0% | $2.58M-35.0% | $2.58M-35.0% | ||
| -$4.4M-3.5% | —— | —— | —— | -$4.25M-50.5% | ||
| -$148K+54.7% | -$1.39M-1,549% | $0+100% | -$298K+27.0% | -$327K-1,735% | ||
| -$3.22M-1,678% | $462K-88.2% | $3M+113% | -$242K+54.2% | -$181K+92.4% | ||
| —— | $468.75K+342% | $468.75K+342% | $468.75K+342% | $468.75K+342% | ||
| -$188K-160% | —— | $1.32M+227% | $358K+739% | $312K+476% | ||
| $16.44M+448% | $15.41M+450% | $10.96M+152% | $5.39M+2.7% | $3M-50.0% | ||
| $0-100% | $101K+153% | $373K-14.1% | $162K-85.7% | $250K-46.1% | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| $2.33M+307% | $3.24M+256% | $1.84M+124% | $1.18M+44.7% | $573K-41.1% | ||
| $3K-70.0% | $4K+107% | $9K— | $10K+121% | $10K-37.5% | ||
| $0-100% | $0-100% | $67K-86.1% | $406K-21.9% | $502K-30.9% | ||
| $2.5M0.0% | $2.5M0.0% | $2.5M0.0% | $2.5M— | $2.5M— | ||
| $58K-89.5% | -$450K-4,600% | $360K— | -$462K-267% | $552K+2,023% | ||
| -$252K-2,700% | $2K— | $59K+192% | $56K— | -$9K-150% | ||
| —— | $0— | $0— | $0— | $0— | ||
| -$658K-142% | —— | $5.74M+14.7% | $7.45M+20.5% | $1.55M+134% | ||
| -$658K-142% | —— | $5.74M+14.7% | $7.45M+20.5% | $1.55M+134% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does BioLife Solutions generate?
- BioLife Solutions (BLFS) generated $17.9M in operating cash flow over the trailing twelve months.
- What is BioLife Solutions's free cash flow?
- After $9.6M of capital expenditures, BioLife Solutions's free cash flow was $14.1M over the trailing twelve months, up 110.7% year over year.
- Where does BioLife Solutions's cash flow data come from?
- Every line is extracted from BioLife Solutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
